These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5565858)

  • 41. [Treatment of parkinsonism with L-dopa].
    Presthus J
    Nord Med; 1970 Nov; 84(46):1467-8. PubMed ID: 5479940
    [No Abstract]   [Full Text] [Related]  

  • 42. L-dopa in the treatment of Parkinsonism; a preliminary appraisal.
    Stellar S; Mandell S; Waltz JM; Cooper IS
    J Neurosurg; 1970 Mar; 32(3):275-80. PubMed ID: 5416909
    [No Abstract]   [Full Text] [Related]  

  • 43. [Study of H and T reflexes in Parkinsonism. Modification of these reflexes by L-Dopa].
    Krassoievitch M; Tissot R
    Encephale; 1971; 60(1):36-57. PubMed ID: 4253001
    [No Abstract]   [Full Text] [Related]  

  • 44. Improvement in mono-manual dexterity in parkinsonism when supplementing levodopa with an extracerebral decarboxylase inhibitor, RO 4-4602.
    Knutsson E; Mårtensson A
    Scand J Rehabil Med; 1974; 6(2):89-93. PubMed ID: 4837060
    [No Abstract]   [Full Text] [Related]  

  • 45. A hort-term evaluation of L-dopa therapy in 34 patients with parkinsonism.
    Mones RJ; Elizan TS
    J Mt Sinai Hosp N Y; 1969; 36(6):503-15. PubMed ID: 5261089
    [No Abstract]   [Full Text] [Related]  

  • 46. [Results of psychometic tests in 23 patients with Parkinson's disease after 6 months treatment with L-dopa].
    Barbizet J; Duizabo P; Pasquier M
    Rev Neurol (Paris); 1972 Aug; 127(2):311-3. PubMed ID: 4666638
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of parkinsonism with L-dopa].
    Court J; Kase JC; Palacios E; Mena I
    Rev Med Chil; 1971 Jun; 99(6):399-401. PubMed ID: 5561157
    [No Abstract]   [Full Text] [Related]  

  • 48. L-dopa in the treatment of Parkinsonism.
    Brezný I; Buranová D; Cernácek J; Trávniková M
    Act Nerv Super (Praha); 1972; 14(2):96. PubMed ID: 5040182
    [No Abstract]   [Full Text] [Related]  

  • 49. L-DOPA treatment for Parkinsonism: analysis of functional improvement.
    Jonas S
    Arch Phys Med Rehabil; 1971 Dec; 52(12):560-2. PubMed ID: 5136441
    [No Abstract]   [Full Text] [Related]  

  • 50. Emotional functions in short-term vs. long-term L-Dopa therapy in Parkinsonism.
    Maskin MB; Riklan M; Chabot D
    J Clin Psychol; 1973 Oct; 29(4):493-5. PubMed ID: 4148857
    [No Abstract]   [Full Text] [Related]  

  • 51. [Longtime study on the effects of L-dopa therapy in parkinsonism].
    Fischer PA; Schneider E; Jacobi P; Maxion H
    Nervenarzt; 1973 Mar; 44(3):128-35. PubMed ID: 4572536
    [No Abstract]   [Full Text] [Related]  

  • 52. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
    Antonini F; Baroni A; Roveyaz L
    Sist Nerv; 1970; 22(2):74-81. PubMed ID: 5504560
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical experience with L-DOPA in the treatment of parkinsonism].
    Chiba T
    No To Shinkei; 1970 Dec; 22(12):1399-405. PubMed ID: 5536833
    [No Abstract]   [Full Text] [Related]  

  • 54. Quantitative measurements of L-dopa therapy in Parkinson's disease.
    Webster DD
    Trans Am Neurol Assoc; 1969; 94():348-50. PubMed ID: 5374483
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of L-dopa on seborrhoea of parkinsonism.
    Wyburn-Mason R
    Lancet; 1970 Jul; 2(7664):154. PubMed ID: 4194540
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effects of L-dopa on mental functions in parkinsonism].
    Violon A; Peypers J; Rappel M
    Acta Psychiatr Belg; 1972 Mar; 72(2):168-84. PubMed ID: 5056014
    [No Abstract]   [Full Text] [Related]  

  • 57. Long-term treatment of Parkinsonism with L-dopa.
    Presthus J; Holmsen R
    Acta Neurol Scand Suppl; 1972; 51():131-2. PubMed ID: 4514340
    [No Abstract]   [Full Text] [Related]  

  • 58. [Attempt at treating parkinsonism with L-dopa and Artane].
    Stelmasiak Z; Lackowska H; Maksymowicz B
    Pol Tyg Lek; 1971 Aug; 26(34):1325-6. PubMed ID: 5110789
    [No Abstract]   [Full Text] [Related]  

  • 59. L-dopa: effect on highest integrative functions in Parkinsonism.
    Guthrie TC; Dunbar HS; Weider A
    Trans Am Neurol Assoc; 1970; 95():250-2. PubMed ID: 5514382
    [No Abstract]   [Full Text] [Related]  

  • 60. Quantitative analysis of the effects of L-dopa on gait in 26 patients with Parkinsonism.
    Peterson CR; Calvert JC; Canzoneri J; Leavitt LA; McCutchen JJ; Schwartz L
    Am J Phys Med; 1972 Aug; 51(4):171-81. PubMed ID: 5052844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.